Who Paid My Doc
John Bagwell
Hematology & Oncology Raton, NM Medical Doctor
NPI 1568424356 CMS profile 25823
203 Hospital Dr, Raton, NM 87740
General payments
$232
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, John Bagwell of Raton, NM is reported in the CMS Open Payments database as having received $232 across 8 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 18th percentile of Hematology & Oncology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $100 | 1 | |
| 2022 | General | $36 | 2 | |
| 2021 | General | $97 | 5 |
Beside peers
- John Bagwell
- Hematology & Oncology median
- Middle half of Hematology & Oncology
- National median
In program year 2025, general payments to John Bagwell were reported at $0. Among 8,769 Hematology & Oncology profiles paid that year, the median was $683 and the middle half received between $143 and $3,154.
Show as a table
| Year | John Bagwell | Hematology & Oncology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $529 | $121–$2,516 | $163 |
| 2020 | $0 | $339 | $82–$2,213 | $114 |
| 2021 | $97 | $263 | $49–$1,965 | $132 |
| 2022 | $36 | $416 | $103–$2,395 | $149 |
| 2023 | $100 | $542 | $125–$2,646 | $160 |
| 2024 | $0 | $692 | $141–$3,008 | $164 |
| 2025 | $0 | $683 | $143–$3,154 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 10 billing codesPaid by Medicare
$540
Medicare patients
14
Services billed
48
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
8 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Hematology & Oncology in New Mexico
Ursa Brown Glaberman
Hematology & Oncology · Albuquerque, NM
Neda Hashemi Sadraei
Hematology & Oncology · Albuquerque, NM
Muhammad Tarakji
Hematology & Oncology · Albuquerque, NM
Yara Abdou
Hematology & Oncology · Albuquerque, NM
Sardar Imam
Hematology & Oncology · Farmington, NM
George Atweh
Hematology & Oncology · Albuquerque, NM
Related records
Hematology & Oncology in New Mexico
Practitioners in the same specialty and state, ranked by reported value.
All Hematology & Oncology
Everyone recorded under this specialty, nationwide.
Doctors in New Mexico
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.